The Paragon Report Provides Stock Research on Baidu and Qihoo
Continue ReadingTag: stock-market
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on AspenBio Pharma and Cadence Pharmaceuticals
Continue Reading
Chinese Internet Companies Predict Slowing Advertising Revenues in the Fourth Quarter
The Paragon Report Provides Stock Research on Dangdang and Renren
Continue Reading
Restaurant Industry Continue to Battle Slowing Economies in the U.S., Europe and China in 2012
The Paragon Report Provides Stock Research on McDonald-s and Yum! Brands
Continue Reading
U.S. to Become the World-s Top Oil Producer by 2020 — Oil Imports to Fall by More Than 50% Within the Next Decade
The Paragon Report Provides Stock Research on Enerplus and Royale Energy
Continue Reading
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Chelsea Therapeutics and Celsion
Continue Reading
U.S. Markets Fall to Three-Month Slows as Fiscal Cliff Looms Closer — Microsoft and Dell Continue to Battle Falling PC Sales
Five Star Equities Provides Stock Research on Microsoft and Dell
Continue Reading
REITs Begin to Struggle as Stimulus Measures From the Federal Reserve Pressure Spreads and Bond Yields Lower
Five Star Equities Provides Stock Research on Hatteras Financial and Two Harbors Investment
Continue Reading
European Commission Begins “Anti-Dumping” Investigation on Chinese Solar Manufacturers
The Paragon Report Provides Stock Research on Yingli Green Energy and LDK Solar
Continue Reading
FDA Considering Faster Pathway for Obesity Treatments, Life-Saving Antibiotics and Other Drugs Deemed to Offer Societal Benefit
The Paragon Report Provides Stock Research on Arena Pharmaceuticals and VIVUS
Continue Reading